We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
49 hedge funds and large institutions have $58.1M invested in Regulus Therapeutics in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
2% more funds holding
Funds holding: 48 → 49 (+1)
0.05% less ownership
Funds ownership: 0.5% → 0.45% (-0.05%)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
25% less capital invested
Capital invested by funds: $77.2M → $58.1M (-$19M)
Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$1.08M |
| 3 |
AC
Ascend Capital
Orinda,
California
|
+$1.07M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$414K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$105K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$6.55M |
| 2 |
BC
Broadfin Capital
New York
|
-$2.94M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$543K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$433K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$255K |
